Key Takeaways
- The UK is facing its fifth heatwave of 2026, with temperatures forecast to reach 33 °C–36 °C in parts of England.
- Certain prescription and over‑the‑counter medications can impair the body’s ability to regulate temperature, stay hydrated, or tolerate sunlight during extreme heat.
- Diuretics, some antidepressants, antipsychotics, and beta‑blockers increase dehydration risk or blunt heat‑stress responses.
- NSAIDs (ibuprofen, naproxen), specific antibiotics (doxycycline, tetracycline), acne treatments (isotretinoin, topical retinoids), antifungals (voriconazole), and DMARDs (methotrexate, azathioprine) heighten sun sensitivity.
- Public health advice stresses hydration, avoiding midday sun, wearing protective clothing and sunscreen, checking medication leaflets, and never stopping prescribed drugs without professional guidance.
- Warning signs of heat‑related distress include dizziness, headaches, unusual fatigue, confusion, and reduced urination; seeking medical help promptly is essential.
Current Heatwave Outlook and Government Alerts
Meteorologists predict that a fifth heatwave will sweep across the United Kingdom in mid‑2026, pushing temperatures into the low‑to‑mid‑30s °C and potentially climbing to 36 °C in East Anglia and the southeast by Thursday. The Met Office has issued yellow heat‑health alerts for the affected regions, signalling that vulnerable populations—including older adults, children, and those with chronic illnesses—face heightened risk of heat‑related illness. In response, the Department of Health and Social Care has reinforced its advisory to the public, emphasizing that medication users must take extra precautions during these extreme conditions.
How Medications Interfere with Thermoregulation
The Medicines and Healthcare products Regulatory Agency (MHRA) highlighted that several classes of drugs can disrupt the body’s natural cooling mechanisms. Diuretics, commonly prescribed for hypertension and heart failure, increase urine output and thus accelerate fluid loss, making dehydration more likely even when fluid intake appears adequate. Some antidepressants and antipsychotics possess anticholinergic properties that reduce sweating, limiting the body’s ability to dissipate heat through evaporation. Beta‑blockers, while beneficial for cardiovascular health, can blunt the heart’s response to heat stress, lowering cardiac output when the body needs to pump more blood to the skin for cooling.
Specific Drug Classes That Heighten Dehydration Risk
Beyond diuretics, certain medications indirectly exacerbate fluid imbalance. For example, laxatives and some chemotherapy agents can cause gastrointestinal fluid loss, while corticosteroids may increase blood glucose levels, prompting osmotic diuresis. Patients taking these drugs should monitor their fluid intake closely, consider weighing themselves daily to detect sudden weight loss (a surrogate for fluid loss), and consult their healthcare provider about adjusting doses during prolonged heat spells.
Medications That Increase Sun Sensitivity
A second major concern involves drugs that render the skin more vulnerable to ultraviolet (UV) radiation, thereby raising the risk of sunburn, phototoxic reactions, and long‑term skin damage. Non‑steroidal anti‑inflammatory drugs (NSAIDs) such as ibuprofen and naproxen are known to cause photosensitivity in some individuals. Likewise, tetracycline‑class antibiotics (doxycycline, tetracycline) and the antifungal agent voriconazole can provoke severe skin reactions upon sun exposure. Acne treatments—including isotretinoin and topical retinoids—also thin the stratum corneum, making the epidermis less protective against UV rays.
Immunomodulatory Agents and Photosensitivity
Disease‑modifying antirheumatic drugs (DMARDs) represent another group warranting caution. Methotrexate and azathioprine, frequently prescribed for rheumatoid arthritis, psoriatic arthritis, and lupus, can increase susceptibility to UV‑induced skin damage and may even elevate the risk of skin cancer with chronic exposure. Patients on these medications are advised to adopt rigorous sun‑protection measures, including broad‑spectrum sunscreen (SPF 30 or higher), wide‑brimmed hats, and UV‑blocking clothing, especially during peak sunlight hours (10 a.m.–4 p.m.).
Practical Strategies to Mitigate Heat‑Related Risks
Dr Alison Cave, MHRA Chief Safety Officer, outlined a series of actionable steps for medication users during heatwaves. Staying hydrated is paramount; individuals should aim for regular sips of water rather than waiting until thirst develops, and they may benefit from electrolyte‑replenishing beverages if they are losing significant sweat. Avoiding direct sun during the hottest part of the day, seeking shade or air‑conditioned environments, and wearing loose, light‑coloured clothing can drastically reduce heat strain. Applying sunscreen liberally and reapplying every two hours—or after swimming or sweating—helps counteract photosensitivity.
Importance of Medication Leaflets and Professional Consultation
Patients are urged to read the patient information leaflet accompanying each medication, as it often contains specific warnings about heat exposure, dehydration, or photosensitivity. Crucially, the MHRA stresses that no one should discontinue a prescribed medication solely based on heat‑related concerns without first consulting a doctor or pharmacist. Abrupt cessation of drugs such as beta‑blockers, anticoagulants, or immunosuppressants can precipitate serious health complications that outweigh the temporary discomfort of heat.
Recognising Warning Signs of Heat Stress
Early detection of heat‑related distress can prevent progression to more severe conditions like heat exhaustion or heat stroke. Symptoms to watch for include dizziness or light‑headedness, persistent headaches, unusual fatigue or weakness, confusion or disorientation, and a noticeable decrease in urination despite adequate fluid intake. If any of these signs appear, individuals should move to a cooler environment, rehydrate, and seek medical advice promptly, especially if symptoms worsen or do not improve within 30 minutes.
Regional Forecasts and Expected Peaks
The Met Office’s detailed forecast indicates that the South and South‑East of England will bear the brunt of the impending heat, with temperatures likely to hover around 33 °C on Sunday and climb further through the week. By Thursday, parts of East Anglia and the southeast could experience highs of 36 °C, meeting the criteria for a formal heatwave definition (three consecutive days of daily maximum temperatures meeting or exceeding the regional threshold). These projections underscore the urgency of adhering to the public health guidance outlined above, particularly for those managing chronic conditions with medication.
Conclusion: Balancing Treatment and Heat Safety
While the current heatwave poses notable challenges, the core message remains clear: medication adherence should not be sacrificed for short‑term comfort, but neither should patients ignore the heightened physiological demands placed on their bodies by extreme heat. By integrating proactive hydration, diligent sun protection, vigilant symptom monitoring, and open communication with healthcare professionals, individuals can safely navigate the heatwave while continuing to benefit from their essential therapies. The combined efforts of the MHRA, Met Office, and public health agencies aim to equip the population with the knowledge and tools necessary to stay healthy during this unusually hot period.